Wealthfront Advisers’s Medline Inc MDLN Stock Holding History

Wealthfront Advisers’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,574	Closed	-$471K	–	1137
2026 Q1	$471K	Buy	+10,574	New	+$467K	﹤0.01%	848

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $2.8B AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

ECU

Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.66% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wealthfront Advisers's MDLN Position: Q2 2026 in Review

Wealthfront Advisers sold out of Medline Inc (MDLN) in Q2 2026, closing a stake of 10,574 shares — an estimated $471K sold.

Wealthfront Advisers first reported a position in MDLN in Q1 2026 and held it in 1 quarter. The position peaked at $471K in Q1 2026. 231 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

Wealthfront Advisers reported no remaining Medline Inc position as of Q2 2026 after selling out during the quarter.
Wealthfront Advisers sold 10,574 Medline Inc shares in Q2 2026, an estimated $471K.
Wealthfront Advisers first reported a position in Medline Inc in Q1 2026 and held it in 1 quarter.
Wealthfront Advisers's Medline Inc position peaked at $471K in Q1 2026.
231 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Wealthfront Advisers's 13F filing for Q2 2026, filed 7 Aug 2026.